Cargando…
PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1
INTRODUCTION: : Paired-related homeobox transcription factor 2 (PRRX2) has been proved involves in the pathogenesis of tumors, but the role of PRRX2 in lung adenocarcinoma (LUAD) is basically not clear. MATERIALS AND METHODS: : LUAD datasets were obtained from Gene Expression Omnibus datasets. Funct...
Autores principales: | Liu, Lihua, Liu, Aihua, Liu, Xuezheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661514/ https://www.ncbi.nlm.nih.gov/pubmed/36379103 http://dx.doi.org/10.1016/j.tranon.2022.101586 |
Ejemplares similares
-
PRRX1 promotes malignant properties in human osteosarcoma
por: Joko, Ryoji, et al.
Publicado: (2020) -
Resident Prrx1 lineage stromal cells promote T cell survival in the spleen
por: Zhang, Wanyao, et al.
Publicado: (2019) -
Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
por: Zhao, Huihui, et al.
Publicado: (2022) -
Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020) -
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
por: Rubio, Andres J., et al.
Publicado: (2021)